We investigated the treatment and prognosis of pleural effusion (PE) in multiple myeloma (MM) patients. From June 2005 to December 2013, 296 MM patients participated in this study. There were 23 PE patients, including 11 men and 12 women, with a median age of 56.8 years (range 37-68 years). A diagnosis of PE was based on physical examination, chest X-ray or computed tomography, and pleural fluid analysis. All patients demonstrated myeloma cells in the pleural fluid, and six patients were positive for PE M protein. PE patients received bortezomib combined with other drugs. Only one patient demonstrated a complete response; 10 patients showed partial responses, and 12 patients developed progressive disease and died. MM linked with myelomatous PE is associated with a poor prognosis. Myelomatous PE is likely a late manifestation of the natural history of MM or an expression of the aggressive behavior of the disease.
第一作者单位：[1]Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing 100043, Peoples R China[*1]Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, 5 Jingyuan Rd, Beijing 100043, Peoples R China
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, Beijing 100043, Peoples R China[*1]Capital Med Univ, Beijing Chao Yang Hosp, Dept Hematol, 5 Jingyuan Rd, Beijing 100043, Peoples R China
推荐引用方式(GB/T 7714)：
Zhong Yuping,Zhang Jiajia,Wang Huan.Myelomatous pleural effusion involvement in 23 patients with multiple myeloma: A single-center clinical analysis[J].THORACIC CANCER.2015,6(3):359-362.doi:10.1111/1759-7714.12220.
APA：
Zhong, Yuping,Zhang, Jiajia&Wang, Huan.(2015).Myelomatous pleural effusion involvement in 23 patients with multiple myeloma: A single-center clinical analysis.THORACIC CANCER,6,(3)
MLA：
Zhong, Yuping,et al."Myelomatous pleural effusion involvement in 23 patients with multiple myeloma: A single-center clinical analysis".THORACIC CANCER 6..3(2015):359-362
